These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9656674)

  • 1. [A case of pleuritis caused by strongyloides in a carrier of T-cell lymphoma virus type I (HTLV-I)].
    Oya H; Mori S; Tsuchihashi H; Kurono A; Mizoguchi A; Kawabata M; Arimura K; Osame M
    Nihon Kokyuki Gakkai Zasshi; 1998 Mar; 36(3):262-7. PubMed ID: 9656674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric strongyloidiasis and infection by the human T cell lymphotropic virus type 1 (HTLV-1).
    Lambertucci JR; Leão FC; Barbosa AJ
    Rev Soc Bras Med Trop; 2003; 36(4):541-2. PubMed ID: 12937738
    [No Abstract]   [Full Text] [Related]  

  • 3. Secondary Strongyloides stercoralis prophylaxis in patients with human T-cell lymphotropic virus type 1 infection: report of two cases.
    Peters L; McCarthy AE; Faught C
    Int J Infect Dis; 2009 Nov; 13(6):e501-3. PubMed ID: 19501008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis.
    Gabet AS; Mortreux F; Talarmin A; Plumelle Y; Leclercq I; Leroy A; Gessain A; Clity E; Joubert M; Wattel E
    Oncogene; 2000 Oct; 19(43):4954-60. PubMed ID: 11042682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aseptic purulent meningitis in two patients co-infected by HTLV-1 and Strongyloides stercoralis].
    Foucan L; Genevier I; Lamaury I; Strobel M
    Med Trop (Mars); 1997; 57(3):262-4. PubMed ID: 9513154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment failure in intestinal strongyloidiasis: an indicator of HTLV-I infection.
    Terashima A; Alvarez H; Tello R; Infante R; Freedman DO; Gotuzzo E
    Int J Infect Dis; 2002 Mar; 6(1):28-30. PubMed ID: 12044298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disseminated Strongyloides stercoralis infection in HTLV-1-associated adult T-cell leukemia/lymphoma.
    Stewart DM; Ramanathan R; Mahanty S; Fedorko DP; Janik JE; Morris JC
    Acta Haematol; 2011; 126(2):63-7. PubMed ID: 21474923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous manifestations of Strongyloides stercoralis hyperinfection in an HIV-seropositive patient.
    Martin SJ; Cohen PR; MacFarlane DF; Grossman ME
    Skinmed; 2011; 9(3):199-202. PubMed ID: 21675505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe strongyloidiasis complicated by meningitis and hydrocephalus in an HTLV-1 carrier with increased proviral load.
    Satoh M; Futami A; Takahira K; Kodaira M; Tanaka T; Kuriki K; Hori E
    J Infect Chemother; 2003 Dec; 9(4):355-7. PubMed ID: 14691660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Enterococcal meningitis due to strongyloidiasis with HTLV-1 carrier].
    Sugiura A; Fujimoto M; Saida Y
    Rinsho Shinkeigaku; 2006 Oct; 46(10):715-7. PubMed ID: 17323782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the prevalence of HTLV-1 infection higher in Strongyloides carriers than in non-carriers?
    Arakaki T; Asato R; Ikeshiro T; Sakiyama K; Iwanaga M
    Trop Med Parasitol; 1992 Sep; 43(3):199-200. PubMed ID: 1470843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis.
    Carvalho EM; Da Fonseca Porto A
    Parasite Immunol; 2004; 26(11-12):487-97. PubMed ID: 15771684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactive arthritis induced by Strongyloides stercoralis.
    Brocq O; Breuil V; Agopian V; Grisot C; Flory P; Bernard-Pomier G; Ziegler G; Euller-Ziegler L
    Rev Rhum Engl Ed; 1996 Mar; 63(3):217-9. PubMed ID: 8731241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recurrent strongyloidiasis as an indicator of HTLV-1 infection].
    Richter J; Schwarz U; Duwe S; Ellerbrok H; Poggensee G; Pauli G
    Dtsch Med Wochenschr; 2005 Apr; 130(16):1007-10. PubMed ID: 15830313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined infection with HTLV-1 and Strongyloides stercoralis].
    Pays JF
    Bull Soc Pathol Exot; 2011 Aug; 104(3):188-99. PubMed ID: 21800110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical clinical presentation of strongyloidiasis in a patient co-infected with human T cell lymphotrophic virus type I.
    Porto MA; Alcântara LM; Leal M; Castro N; Carvalho EM
    Am J Trop Med Hyg; 2005 Feb; 72(2):124-5. PubMed ID: 15741545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case study: Fatal strongyloidiasis associated with human T-cell lymphotropic virus type 1 infection.
    Adedayo AO; Grell GA; Bellot P
    Am J Trop Med Hyg; 2001 Nov; 65(5):650-1. PubMed ID: 11716131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strongyloides stercoralis: a cause of morbidity and mortality for indigenous people in Central Australia.
    Einsiedel L; Fernandes L
    Intern Med J; 2008 Sep; 38(9):697-703. PubMed ID: 19143887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 56-year-old woman with rash, paralytic ileus, and massive gastrointestinal bleeding.
    Seas C; Legua P
    Clin Infect Dis; 2009 Oct; 49(7):1094-5, 1132-3. PubMed ID: 19739959
    [No Abstract]   [Full Text] [Related]  

  • 20. Intestinal strongyloidiasis manifesting as eosinophilic pleural effusion.
    Goyal SB
    South Med J; 1998 Aug; 91(8):768-9. PubMed ID: 9715228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.